WebJul 20, 2024 · Biogen Reports Second Quarter 2024 Results Second quarter revenue $2,589 million; GAAP diluted EPS $7.24; Non-GAAP diluted EPS $5.25 FDA granted Priority Review for lecanemab in early Alzheimer's disease under the accelerated approval pathway with a decision expected by January 6, 2024; Phase 3 data expected in the Fall of 2024 WebJul 20, 2024 · Published. Jul 20, 2024 09:14AM EDT. Biogen BIIB reported second-quarter 2024 earnings per share (EPS) of $5.25, which significantly beat the Zacks Consensus Estimate of $4.10. In the year-ago ...
Biogen Q4 2024 Earnings Call Transcript - marketbeat.com
WebJul 20, 2024 · Biogen also raised its 2024 forecast Wednesday. It now expects adjusted earnings of $15.25 to $16.75 per share, up from a previous forecast of $14.25 to $16 per share that it had reaffirmed in the spring. Analysts are forecasting earnings of $15.43 per share. The company offered no updates Wednesday on its search for a new leader to … WebFeb 3, 2024 · Biogen revealed in its earnings report on Thursday that Aduhelm brought in $3 million in 2024, about 0.03% of the company's total revenue for the year. It will be a while before Aduhelm has the ... signs and symptoms of cva stroke
Biogen Skids Despite Beat-And-Raise As Alzheimer
WebEarnings Data Report Date Apr 26, 2024 Not Confirmed Period Ending 2024 (Q1) Consensus EPS Forecast $3.39 Last Year’s EPS $3.62 Same Quarter Last Year Analyst Consensus Strong Buy Based on 20 Analysts Ratings Biogen (BIIB) Earnings, Revenues Date & History Earnings Revenues WebOct 20, 2024 · 3 May 2024: Q1 2024 Earnings Call Transcript Q4 2024. 3 February 2024: Q4 2024 Earnings Call Transcript ... CEO Michel Vounatsos on Q2 2024 Results - Earnings Call Transcript Q2 2024. 23 July 2024: Q2 2024 Earnings Call Transcript 2024. ... Biogen Idec Inc. Q2 2010 Earnings Call Transcript Q1 2010. 20 April 2010: WebJul 19, 2024 · In the second quarter of 2024, our adjusted income before tax for the enterprise as a percentage of sales increased from 33.4% to 34%, primarily driven by favorable product and segment mix,... signs and symptoms of cmt